{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T02:37:03Z","timestamp":1788057423094,"version":"build-2784847793"},"reference-count":26,"publisher":"Scientific Scholar","content-domain":{"domain":["cytojournal.com"],"crossmark-restriction":true},"short-container-title":["Cytojournal"],"abstract":"<jats:sec id=\"st1\">\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Hypoxia-inducible factor 1 (HIF-1) signaling mediates multiple links of wound healing. Tissue hypoxia and dysregulation of HIF-1 signal play a crucial role in non-healing diabetic wounds. Previous studies have found that roxadustat (FG-4592) can promote epidermal stem cell proliferation by upregulating the HIF signaling pathway. This study aimed to investigate the role of roxadustat in the wound healing of diabetic mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st2\">\n                    <jats:title>Material and Methods:<\/jats:title>\n                    <jats:p>\n                      The study was divided into\n                      <jats:italic>in vivo<\/jats:italic>\n                      and\n                      <jats:italic>in vitro<\/jats:italic>\n                      experiments. In the\n                      <jats:italic>in vivo<\/jats:italic>\n                      experiment, mice were categorized into three groups: control group, diabetes group, and diabetes + roxadustat group. Diabetic mice were injected intraperitoneally with roxadustat daily at a dose of 10 mg\/kg. Hematoxylin &amp; eosin staining and Masson staining were employed to assess wound healing speed and quality. Immunohistochemical staining was used to detect HIF-1a and proliferating cell nuclear antigens. Western blot was conducted to examine markers associated with Notch1 signaling pathway activation (Notch Intracellular Domain [NICD]), keratinocyte differentiation, and angiogenesis. In the\n                      <jats:italic>in vitro<\/jats:italic>\n                      experiment, HaCaT cells were divided into control (Glu 5.5 mM), high-glucose (Glu 30 mM), and high-glucose + drug (Glu 30 mM + FG-4592) groups, with a treatment concentration of FG-4592 set at 10 \u00b5M. Following 48 h of treatment period, protein was extracted for co-immunoprecipitation analysis to determine the interaction between HIF-1a and NICD, and fluorescence staining was conducted to assess their co-localization.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st3\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Roxadustat reversed the slow wound healing caused by diabetes and significantly improved the quality of healing (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.05). It upregulated the inhibited HIF-1 signaling in diabetic mice (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.05) and triggered cell proliferation. It downregulated the hyperactivated Notch1 signaling in diabetic mice (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.05) and induced keratinocyte dedifferentiation, which were both responsible for wound re-epithelialization. Roxadustat also reversed the downregulated expression of vascular endothelial growth factor and CD31 in diabetic mice (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.05) and accelerated the wound angiogenesis process.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st4\">\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Roxadustat shows potential as a therapeutic drug by promoting re-epithelialization and angiogenesis to bring vigor to the impaired diabetic wound.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.25259\/cytojournal_235_2024","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:00:20Z","timestamp":1762254020000},"page":"90","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Roxadustat: A catalyst for diabetic wound healing through re-epithelialization and angiogenesis"],"prefix":"10.25259","volume":"22","author":[{"given":"Di","family":"Tang","sequence":"first","affiliation":[{"name":"Department of Burn and Plastic Surgery, General Hospital of Central Theater Command, Wuhan, China"},{"name":"Graduate Joint Training Base of Wuhan University of Science and Technology and Central Theater Command General Hospital, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Lin","sequence":"additional","affiliation":[{"name":"Graduate Joint Training Base of Wuhan University of Science and Technology and Central Theater Command General Hospital, Wuhan, China"},{"name":"School of Medicine, Wuhan University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Burn and Plastic Surgery, General Hospital of Central Theater Command, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-ping","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, General Hospital of Central Theater Command, Wuhan, China,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"10.25259\/Cytojournal_235_2024\/ref-1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"key":"10.25259\/Cytojournal_235_2024\/ref-2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00125-021-05380-z","article-title":"Hypoxia and hypoxia-inducible factors in diabetes and its complications","volume":"64","author":"Catrina","year":"2021","journal-title":"Diabetologia"},{"key":"10.25259\/Cytojournal_235_2024\/ref-3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.5603\/DK.a2022.0004","article-title":"The role of keratinocyte function on the defected diabetic wound healing","volume":"11","author":"Hosseini Mansoub","year":"2021","journal-title":"Int J Burns Trauma"},{"key":"10.25259\/Cytojournal_235_2024\/ref-4","doi-asserted-by":"publisher","first-page":"637","DOI":"10.14348\/molcells.2014.0150","article-title":"Regulation of wound healing and fibrosis by hypoxia and hypoxiainducible factor-1","volume":"37","author":"Ruthenborg","year":"2014","journal-title":"Mol Cells"},{"key":"10.25259\/Cytojournal_235_2024\/ref-5","doi-asserted-by":"publisher","first-page":"S0022-202X(24)02951-8","DOI":"10.1016\/j.jid.2024.09.022","article-title":"Constitutive HIF-1\u03b1 expression in the epidermis fuels proliferation and is essential for effective barrier formation","volume":"22","author":"Boix","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.25259\/Cytojournal_235_2024\/ref-6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1113\/JP280572","article-title":"Regulation of glycolysis by the hypoxiainducible factor (HIF): Implications for cellular physiology","volume":"599","author":"Kierans","year":"2021","journal-title":"J Physiol"},{"key":"10.25259\/Cytojournal_235_2024\/ref-7","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.1172\/JCI137556","article-title":"Hypoxia-inducible factors and diabetes","volume":"130","author":"Gunton","year":"2020","journal-title":"J Clin Invest"},{"key":"10.25259\/Cytojournal_235_2024\/ref-8","doi-asserted-by":"publisher","first-page":"e2202751","DOI":"10.1002\/adhm.202202751","article-title":"Dapagliflozin-loaded exosome mimetics facilitate diabetic wound healing by HIF-1\u03b1-mediated enhancement of angiogenesis","volume":"12","author":"Zhang","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"10.25259\/Cytojournal_235_2024\/ref-9","doi-asserted-by":"publisher","first-page":"116202","DOI":"10.1016\/j.biopha.2024.116202","article-title":"Pathogenesis of diabetic complications: Exploring hypoxic niche formation and HIF-1\u03b1 activation","volume":"172","author":"Bi","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.25259\/Cytojournal_235_2024\/ref-10","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.7150\/ijms.5630","article-title":"The possible mechanisms underlying the impairment of HIF-1\u03b1 pathway signaling in hyperglycemia and the beneficial effects of certain therapies","volume":"10","author":"Xiao","year":"2013","journal-title":"Int J Med Sci"},{"key":"10.25259\/Cytojournal_235_2024\/ref-11","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1038\/s41467-021-23448-7","article-title":"A small molecule HIF-1\u03b1 stabilizer that accelerates diabetic wound healing","volume":"12","author":"Li","year":"2021","journal-title":"Nat Commun"},{"key":"10.25259\/Cytojournal_235_2024\/ref-12","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJMoa1813599","article-title":"Roxadustat for anemia in patients with kidney disease not receiving dialysis","volume":"381","author":"Chen","year":"2019","journal-title":"N Engl J Med"},{"key":"10.25259\/Cytojournal_235_2024\/ref-13","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1681\/ASN.2015030241","article-title":"Roxadustat (FG-4592): Correction of anemia in incident dialysis patients","volume":"27","author":"Besarab","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.25259\/Cytojournal_235_2024\/ref-14","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1159\/000489652","article-title":"FG-4592 accelerates cutaneous wound healing by epidermal stem cell activation via HIF-1\u03b1 stabilization","volume":"46","author":"Tang","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.25259\/Cytojournal_235_2024\/ref-15","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/wrr.12708","article-title":"Roxadustat promotes angiogenesis through HIF-1\u03b1\/VEGF\/VEGFR2 signaling and accelerates cutaneous wound healing in diabetic rats","volume":"27","author":"Zhu","year":"2019","journal-title":"Wound Repair Regen"},{"key":"10.25259\/Cytojournal_235_2024\/ref-16","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1248\/bpb.34.1037","article-title":"Dedifferentiation of human terminally differentiating keratinocytes into their precursor cells induced by basic fibroblast growth factor","volume":"34","author":"Sun","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"10.25259\/Cytojournal_235_2024\/ref-17","doi-asserted-by":"publisher","first-page":"120616","DOI":"10.1016\/j.lfs.2022.120616","article-title":"Saccharomyces boulardii exerts renoprotection by modulating oxidative stress, renin angiotensin system and uropathogenic microbiota in a murine model of diabetes","volume":"301","author":"Abreu","year":"2022","journal-title":"Life Sci"},{"key":"10.25259\/Cytojournal_235_2024\/ref-18","first-page":"380","article-title":"Effect of Salvia miltiorrhiza combined with roxadustat on wound healing of full-thickness skin defects in diabetic rats and its mechanism","volume":"40","author":"Xia","year":"2024","journal-title":"Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi"},{"key":"10.25259\/Cytojournal_235_2024\/ref-19","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1111\/iwj.14235","article-title":"Roxadustat promotes hypoxia-inducible factor-1\u03b1\/vascular endothelial growth factor signalling to enhance random skin flap survival in rats","volume":"20","author":"Lan","year":"2023","journal-title":"Int Wound J"},{"key":"10.25259\/Cytojournal_235_2024\/ref-20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/dmrr.2742","article-title":"Disturbed hypoxic responses as a pathogenic mechanism of diabetic foot ulcers","volume":"32","author":"Catrina","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"10.25259\/Cytojournal_235_2024\/ref-21","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jconrel.2025.02.010","article-title":"Controlled delivery of HIF-1\u03b1 via extracellular vesicles with collagen-binding activity for enhanced wound healing","volume":"380","author":"Jeon","year":"2025","journal-title":"J Control Release"},{"key":"10.25259\/Cytojournal_235_2024\/ref-22","doi-asserted-by":"publisher","first-page":"695e","DOI":"10.1097\/PRS.0000000000003072","article-title":"Comparison of the hydroxylase inhibitor dimethyloxalylglycine and the iron chelator deferoxamine in diabetic and aged wound healing","volume":"139","author":"Duscher","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"10.25259\/Cytojournal_235_2024\/ref-23","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1128\/MCB.00609-13","article-title":"Loss of epithelial hypoxia-inducible factor prolyl hydroxylase 2 accelerates skin wound healing in mice","volume":"33","author":"Kalucka","year":"2013","journal-title":"Mol Cell Biol"},{"key":"10.25259\/Cytojournal_235_2024\/ref-24","doi-asserted-by":"publisher","first-page":"6985","DOI":"10.1073\/pnas.1900351116","article-title":"Triggering of a Dll4-Notch1 loop impairs wound healing in diabetes","volume":"116","author":"Zheng","year":"2019","journal-title":"P Natl Acad Sci USA"},{"key":"10.25259\/Cytojournal_235_2024\/ref-25","doi-asserted-by":"publisher","first-page":"43926","DOI":"10.1038\/srep43926","article-title":"Notch1 signaling contributes to hypoxia-induced high expression of integrin \u03b21 in keratinocyte migration","volume":"7","author":"Tang","year":"2017","journal-title":"Sci Rep"},{"key":"10.25259\/Cytojournal_235_2024\/ref-26","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1161\/CIRCULATIONAHA.116.024307","article-title":"Dedifferentiation, proliferation, and redifferentiation of adult mammalian cardiomyocytes after ischemic injury","volume":"136","author":"Wang","year":"2017","journal-title":"Circulation"}],"container-title":["Cytojournal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cytojournal.com\/roxadustat-a-catalyst-for-diabetic-wound-healing-through-re-epithelialization-and-angiogenesis\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cytojournal.com\/roxadustat-a-catalyst-for-diabetic-wound-healing-through-re-epithelialization-and-angiogenesis\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:00:20Z","timestamp":1762254020000},"score":1,"resource":{"primary":{"URL":"https:\/\/cytojournal.com\/roxadustat-a-catalyst-for-diabetic-wound-healing-through-re-epithelialization-and-angiogenesis\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":26,"alternative-id":["10.25259\/Cytojournal_235_2024"],"URL":"https:\/\/doi.org\/10.25259\/cytojournal_235_2024","relation":{},"ISSN":["1742-6413","0974-5963"],"issn-type":[{"value":"1742-6413","type":"electronic"},{"value":"0974-5963","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"article-number":"90"}}